Evidence map›Paper›PMID 32803682›Full record

ArticleJournal of nephrology2021

Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis.

Javier Perez-Hernandez, Olga Martinez-Arroyo, Ana Ortega, Miriam Galera, Miguel A Solis-Salguero, Felipe J Chaves, Josep Redon, Maria J Forner, Raquel Cortes

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Urinary extracellular vesicle RNAs as novelClinical kidney journal · 2025
    Article
  18. Review
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Javier Perez-Hernandez *Cardiometabolic and Renal Risk Research Group, INCLIVA Health Research Institute, Avd. Menenzdez Pelayo, acceso 4, 46010, Valencia, Spain.
Olga Martinez-Arroyo *Cardiometabolic and Renal Risk Research Group, INCLIVA Health Research Institute, Avd. Menenzdez Pelayo, acceso 4, 46010, Valencia, Spain.
Ana Ortega *Cardiometabolic and Renal Risk Research Group, INCLIVA Health Research Institute, Avd. Menenzdez Pelayo, acceso 4, 46010, Valencia, Spain.
Miriam GaleraCardiometabolic and Renal Risk Research Group, INCLIVA Health Research Institute, Avd. Menenzdez Pelayo, acceso 4, 46010, Valencia, Spain.
Miguel A Solis-SalgueroNephrology Unit, Hospital Clinico Universitario, 46010, Valencia, Spain.
Felipe J ChavesGenomic and Diabetes Unit, INCLIVA Health Research Institute, 46010, Valencia, Spain.
Josep RedonCardiometabolic and Renal Risk Research Group, INCLIVA Health Research Institute, Avd. Menenzdez Pelayo, acceso 4, 46010, Valencia, Spain.
Maria J Forner *Cardiometabolic and Renal Risk Research Group, INCLIVA Health Research Institute, Avd. Menenzdez Pelayo, acceso 4, 46010, Valencia, Spain.
Raquel Cortes *Cardiometabolic and Renal Risk Research Group, INCLIVA Health Research Institute, Avd. Menenzdez Pelayo, acceso 4, 46010, Valencia, Spain. raquel.cortes@uv.es.ORCID http://orcid.org/0000-0001-9607-997X
INCLIVA Health Research Institute · ESHospital Clínico Universitario de Valencia · ESInstitut Cochin · FR

Funding

Instituto de Salud Carlos III CD18/00166Instituto de Salud Carlos III PI16/1402Instituto de Salud Carlos III PI18/01405
6 · The paper itself

Abstract

backgroundUrinary exosomes, especially microRNAs (miRNAs) packaged within, are ideal sources of renal damage markers. We investigated the association between exosomal miR-146a, (anti-inflammatory regulator) and disease activity, proteinuria and systemic lupus erythematosus (SLE) flares over a 36-month follow-up period.

methodsWe isolated urinary exosomes from 41 SLE patients, 27 with lupus nephritis (LN) and 20 healthy controls, and exosomal miR-146a, quantified by the real-time quantitative polymerase chain reaction (RT-qPCR), was correlated with histological features in 13 renal biopsies. We also analysed the association between the exosomal miR-146a and TRAF6 axis.

resultsExosomal miR-146a showed an inverse association with circulating C3 and C4 complement components, proteinuria, and with histological features such as chronicity index. This marker was able to identify LN with an AUC of 0.82 (p = 0.001). Basal exosomal miR-146a was associated with disease activity and proteinuria changes and was an independent marker of 36-month follow-up flares (OR 7.08, p = 0.02). Pathway analysis identified IRAK1 and TRAF6 as miR-146a target genes. Finally, in vitro experiments suggested that miR-146a exerts a protective effect through negative regulation of inflammation by suppressing IRAK1 and TRAF6.

conclusionsUrinary exosomal miR-146a levels are correlated with lupus activity, proteinuria and histological features, discriminating patients with LN and being a good baseline marker of SLE flares. We have identified a relevant biological miR-146a-TRAF6 axis association in LN renal fibrosis progression.

Indexed as

ExosomesLupus NephritisAlbuminuriaBiomarkersHumansInterleukin-1 Receptor-Associated KinasesIntracellular Signaling Peptides and ProteinsLupus Erythematosus, SystemicMicroRNAsSymptom Flare UpBiomarkersInterleukin-1 Receptor-Associated KinasesIntracellular Signaling Peptides and ProteinsIRAK1 protein, humanMicroRNAsMIRN146 microRNA, humanTifab protein, humanDisease flaresExosomesLupus nephritismicroRNASystemic lupus erythematosus

Identifiers

PMID32803682
OpenAlexW3049495400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.